Agenda
• Introduction to controlled human infection modeling (CHIM)
• SARS-CoV-2: an introduction
• Regulatory considerations surrounding COVID-19 modelling
• Working wiith regulators on COV1D-19 CHIM design and development
• How a COVID-19 CHIM trial could accelerate your pipeline development
• Q&A
Presenters:
Bruno Speder: SGS Head Clinical Regulatory Affairs & Consultancy
Adrian Wildfire: SGS Scientific Director
Robin Rogiers: SGS Investigator
Date and time: Tuesday, April 28, 2020 at 03:00 PM Central European Summer Time
Dedicated registration link here.